These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 31900968)
21. Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors. Le Clech A; Simon-Tillaux N; Provôt F; Delmas Y; Vieira-Martins P; Limou S; Halimi JM; Le Quintrec M; Lebourg L; Grangé S; Karras A; Ribes D; Jourde-Chiche N; Rondeau E; Frémeaux-Bacchi V; Fakhouri F Kidney Int; 2019 Jun; 95(6):1443-1452. PubMed ID: 30982675 [TBL] [Abstract][Full Text] [Related]
22. Where are we with haemolytic uremic syndrome? Cavero T; Alonso M Med Clin (Barc); 2018 Oct; 151(8):329-335. PubMed ID: 29699703 [TBL] [Abstract][Full Text] [Related]
23. First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis. Szarvas N; Szilágyi Á; Tasic V; Nushi-Stavileci V; Sofijanova A; Gucev Z; Szabó M; Szabó A; Szeifert L; Reusz G; Rusai K; Arbeiter K; Müller T; Prohászka Z Ital J Pediatr; 2014 Dec; 40():101. PubMed ID: 25496981 [TBL] [Abstract][Full Text] [Related]
32. A Case Report and Literature Review of Eculizumab Withdrawal in Atypical Hemolytic-Uremic Syndrome. Quiroga B; de Lorenzo A; Vega C; de Alvaro F Am J Case Rep; 2016 Dec; 17():950-956. PubMed ID: 27974740 [TBL] [Abstract][Full Text] [Related]
33. Irreversible severe kidney injury and anuria in a 3-month-old girl with atypical haemolytic uraemic syndrome under administration of eculizumab. Okuda Y; Ishikura K; Terano C; Harada R; Hamada R; Hataya H; Ogata K; Honda M Nephrology (Carlton); 2016 Mar; 21(3):261-5. PubMed ID: 26818219 [TBL] [Abstract][Full Text] [Related]
34. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment. Raina R; Krishnappa V; Blaha T; Kann T; Hein W; Burke L; Bagga A Ther Apher Dial; 2019 Feb; 23(1):4-21. PubMed ID: 30294946 [TBL] [Abstract][Full Text] [Related]
35. Use of Eculizumab in Atypical Hemolytic Uremic Syndrome, Complicating Systemic Lupus Erythematosus. Bermea RS; Sharma N; Cohen K; Liarski VM J Clin Rheumatol; 2016 Sep; 22(6):320-3. PubMed ID: 27556240 [TBL] [Abstract][Full Text] [Related]
36. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series. Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363 [TBL] [Abstract][Full Text] [Related]
37. Overlapping Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy with Mutation in CFI in a Japanese Patient: A Case Report. Osawa K; Yamamoto S; Yamano Y; Kita A; Okamoto K; Kato N; Tatematsu Y; Kojima F; Ohya M; Hara S; Murata SI; Inoue N; Maruyama S; Araki SI Intern Med; 2024 Jun; 63(12):1777-1782. PubMed ID: 37926536 [TBL] [Abstract][Full Text] [Related]
38. Successful kidney transplant with eculizumab, thymoglobulin and belatacept therapy in a highly-sensitised patient with atypical haemolytic uraemic syndrome due to factor H mutation. Nieto-Ríos JF; Zuluaga-Quintero M; Bello-Márquez DC; Aristizabal-Alzate A; Ocampo-Kohn C; Serna-Higuita LM; Arias L; Zuluaga-Valencia G Nefrologia (Engl Ed); 2018; 38(4):433-437. PubMed ID: 29778558 [TBL] [Abstract][Full Text] [Related]
39. Three months interval therapy of Eculizumab in a patient with atypical hemolytic uremic syndrome with hybrid CFHR1/CFH gene. Alobaidi S; AlDabbagh A; Alamoudi A; Almowarey M; Akl A CEN Case Rep; 2019 May; 8(2):139-143. PubMed ID: 30715674 [TBL] [Abstract][Full Text] [Related]
40. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome. Szarvas N; Szilágyi Á; Csuka D; Takács B; Rusai K; Müller T; Arbeiter K; Réti M; Haris Á; Wagner L; Török S; Kelen K; Szabó AJ; Reusz GS; Morgan BP; Prohászka Z Mol Immunol; 2016 Mar; 71():10-22. PubMed ID: 26826462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]